Sun Pharma shares in focus

Sun Pharma drops 5% after US court halts launch of alopecia treatment drug
Despite this setback, Sun Pharma’s stock has rallied 43 per cent year-to-date, fueled by growth in speciality drugs, emerging markets, and domestic sales.
Sun Pharma shares slump 5% after US court ruling stalls Leqselvi launch
In the worst-case scenario, an unfavourable judgment would prevent Sun Pharma from launching Leqselvi until the patent expires, delaying its market entry.
Sun Pharma tumbles after US court halts Leqselvi launch
Sun Pharmaceutical Industries slipped 4.30% to 1,778.85 after the US District Court of New Jersey has decided to grant a preliminary injunction delaying the launch of Leqselvi (Baldness treatment) in the US.
Sun Pharma alopecia drug Leqselvi launch blocked in US
Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in New Jersey has issued a preliminary injunction.
Sun Pharma shares in focus as US court blocks Leqselvi launch
Sun Pharma faces a delay in the U.S. launch of its drug Leqselvi due to a preliminary injunction by the New Jersey court, pending further legal proceedings or patent expiration in December 2026. The company plans to appeal the decision while considering a potential settlement with Incyte.
Sun Pharma's Leqselvi launch in US faces legal roadblock; analysts cautious
This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company wins its appeal, or up to two years if it loses the case entirely
MarketWatch20h
Sun Pharmaceutical Industries outperforms competitors despite losses on the day
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved ...
ndtvprofit7d
Sun Pharma Share Price Rises As Analysts Find Q2 Earnings More Resilient Than Peers
Most brokerages retained ratings and target prices for Sun Pharmaceutical Industries after its second quarter earnings beat ...
Share Market Highlights: Sensex, Nifty mark worst drop in over a month amid US election jitters
Shares of Sun Pharmaceutical fell 2.64 per cent after the pharma major recently announced that the US District Court of ...
devdiscourse8d
Sun Pharma's Q2 Profit Surges, Plans Strategic Expansion
Sun Pharmaceutical Industries has reported a notable 28% increase in its consolidated net profit, amounting to Rs 3,040 crore ...
India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs
Sun Pharmaceuticals , India's largest drugmaker by revenue, reported second-quarter profit above analysts' estimates on ...
Sun Pharma Q2 Results: Net profit rises 28% YoY at ₹3,040.16 crore
Sun Pharmaceutical Industries Ltd on Monday reported an 28% year-on-year rise in its consolidated net profit for the fiscal's ...
devdiscourse8d
Sun Pharma's Profits Soar with Strategic Expansion
Sun Pharmaceutical Industries reported a 28% rise in net profit, reaching Rs 3,040 crore for the September quarter, driven by ...
Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations
Analysts expected India's largest drugmaker's net profit to jump, led by favourable seasonality and strong specialty sales.
ndtvprofit2d
Stock Market Live: Nifty, Sensex Decline At Open As Sun Pharma, Infosys Share Prices Drag
The Nifty 50 and Sensex were trading flat at pre–open. Sun Pharmaceutical Industries Ltd., and Zomato Ltd. may move in Monday ...